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Abstract
Articular cartilage is prone to degeneration and possesses extremely poor self-healing
capacity due to inherent low cell density and the absence of a vasculature network. Tissue
engineered cartilage scaffolds show promise for cartilage repair. However, there still remains
a lack of ideal biomimetic tissue scaffolds which effectively stimulate cartilage regeneration
with appropriate functional properties. Therefore, the objective of this study is to develop a
novel biomimetic and bioactive electrospun cartilage substitute by integrating cold atmo-
spheric plasma (CAP) treatment with sustained growth factor delivery microspheres. Specifi-
cally, CAP was applied to a poly(ε-caprolactone) electrospun scaffold with homogeneously
distributed bioactive factors (transforming growth factor-β1 and bovine serum albumin)
loaded poly(lactic-co-glycolic) acid microspheres. We have shown that CAP treatment ren-
ders electrospun scaffolds more hydrophilic thus facilitating vitronectin adsorption. More
importantly, our results demonstrate, for the first time, CAP and microspheres can synergisti-
cally enhance stem cell growth as well as improve chondrogenic differentiation of human
marrow-derived mesenchymal stem cells (such as increased glycosaminoglycan, type II col-
lagen, and total collagen production). Furthermore, CAP can substantially enhance 3D cell
infiltration (over two-fold increase in infiltration depth after 1 day of culture) in the scaffolds.
By integrating CAP, sustained bioactive factor loaded microspheres, and electrospinning,
we have fabricated a promising bioactive scaffold for cartilage regeneration.
Introduction
Articular cartilage is a connective tissue found in diarthrodial joints which provides a lubri-
cated surface between bones, allowing load transfer while withstanding repetitive loading over
a person’s lifetime. It is a thin layer of tissue on the order of 1–4 mm in thickness depending on
its location within the human body, thus rendering it prone to degeneration as a result of
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trauma, disease, and mechanical overloading [1]. Injuries to cartilaginous tissue can be classi-
fied into three categories: superficial matrix disruption, partial, and full thickness defects.
Amongst them, superficial matrix disruption as a result from blunt trauma can be repaired by
human chondrocytes, but partial thickness defects and full thickness defects are inherently
incapable of self-repair. Therefore, artificial intervention is required to repair injured cartilage
under these conditions. Cartilage regeneration primarily occurs when progenitor cells or chon-
drocytes are accessible and undergo chondrogenesis to form tissue de novo [2]. Following this
logic, multiple treatment options including microfracture, mosaicplasty, and autologous chon-
drocyte implantation have been explored [3]. However, there still remains an ongoing need for
the development of novel strategies due to the poor long-term outcome of these traditional
treatment methods. Tissue engineering as an alternative strategy has presented promise in
repairing cartilage tissue defects [4].
3D tissue engineered scaffolds provide a template and environmental cues to support cell
growth, proliferation, differentiation, and facilitate formation of new tissue. In particular, elec-
trospinning is a versatile scaffold fabrication technique which has gained increased attention in
the realm of cartilage tissue repair [3, 5]. This technique allows for the fabrication of fibrous
scaffolds with biomimetic micro-to-nanoscale diameters closely resembling the porous archi-
tecture of native extracellular matrix. The versatility of electrospinning makes it possible to
obtain scaffolds with controllable geometry, surface chemistry, and mechanical properties by
adjusting the process parameters including polymer molecular weight and concentration,
applied voltage, and flow rate.
A wide variety of biomaterials have been utilized in electrospinning to include poly(ε-capro-
lactone) (PCL) which is one of the most widely used synthetic polymers due to its excellent
biocompatibility, biodegradability, and mechanical properties [6]. Studies have shown the
capacity of PCL fibrous scaffolds to maintain chondrocyte phenotype and upregulate collagen
type IIB splice variant transcript expression (indication of mature chondrocyte phenotype) [7].
Although PCL exhibits desirable characteristics, the materials’ inherent hydrophobic nature
leads to the absence of surface cell-recognition sites limiting its biomedical application [8]. In
an effort to improve cell-scaffold interactions, approaches such as the incorporation of bioac-
tive peptides or proteins, alkaline hydrolysis, blending with other biopolymers, and processing
with plasma deposition have been carried out [9–13]. However, most of these surface modifica-
tion techniques are costly, time consuming, and routinely impair the bulk bioactive properties
of the scaffold. Therefore, a more effective surface modification technique which can maintain
the scaffolds’ bioactive properties while improving cell growth is still desirable.
In an effort to develop such a novel scaffold surface modification technique, we introduce
cold atmospheric plasma (CAP) in this study targeting to render electrospun scaffold with
more bioactivity and cell-favorable surface properties. Unlike traditional high temperature
plasmas, CAP is an ionized gas whose temperature is close to room temperature composed of a
unique environment of charged particles, including reactive oxygen and nitrogen species, pho-
tons, and electrostatic and electromagnetic fields [14]. These unique chemical and physical
properties have enabled its recent application to biomedicine, including sterilization, biomate-
rial preparation, cancer therapy, and dental surgery [15–20]. CAP treatment can serve as an
innovative and effective method to modify materials for particular biological applications. For
instance, when utilizing CAP as a source of treating biological materials, it was demonstrated
that CAP can specifically interact with organic materials without causing thermal/electric dam-
age [21]. In our recent study, after CAP treatment, a lyophilized nanocrystalline hydroxyapa-
tite/chitosan scaffold was induced with a more biomimetic and bioactive surface [22]. Greatly
enhanced human marrow-derived mesenchymal stem cells (MSC) adhesion and osteogenic
differentiation were observed in CAP modified scaffolds associated with increased total
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protein, collagen synthesis, and calcium deposition after 3 weeks of culture. Thus, it is postu-
lated here that CAP modification can create a bioactive implantable cartilage scaffold for
enhanced cell growth and tissue regeneration.
In addition to cell favorable surface chemistry, the incorporation of cell-specific bioactive
factors within scaffolds is significant to improve cell growth and regulate cell behavior. Numer-
ous studies have shown that bioactive factors incorporated within a scaffold matrix can control
cellular function as well as promote successful tissue formation [23]. With this in mind, we fab-
ricated poly(lactic-co-glycolic) acid (PLGA) microspheres with controlled bioactive factor
delivery (bovine serum albumin (BSA) and transforming growth factor-β1 (TGF-ß1)) via a
water/oil/water (w/o/w) double emulsion solvent extraction method for the enhancement of
cell proliferation and induction of chondrogenesis. As a result, the biomimetic cartilage scaf-
fold fabricated in this study integrates CAP, a sustained bioactive factor delivery system, and
electrospinning for synergistic regulation of MSC growth, infiltration, and chondrogenic differ-
entiation. Scaffold morphology, hydrophilicity, surface chemistry, protein adsorption, and
mechanical properties were evaluated, and MSC growth and the induction of chondrogenesis
were subsequently investigated.
Materials and Methods
Fabrication of Electrospun PCL Scaffold with PLGA Microspheres
Fig 1 illustrates the preparation of microsphere-embedded scaffolds with CAP surface modifi-
cation. The electrospun polymer solution was prepared by dissolving PCL (Mw: 70,000–
90,000) in chloroform at a concentration of 20% (w/v). The polymeric solution was then fed
into a 10 mL standard syringe attached to a 26 G blunted stainless steel needle using a syringe
pump at a flow rate of 4.5 mL.h-1 under an applied voltage of 7 kV. Electrospun fibers were col-
lected on a metal plate wrapped with aluminum foil at a distance of 12 cm from the needle tip.
Bioactive factor encapsulated microspheres were synthesized by a modified w/o/w double
emulsion solvent extraction method. Briefly, a BSA (10 mg.mL-1) or TGF-β1/BSA (250 ng.mL-1
TGF-β1 in 10 mg.mL-1 BSA) was dissolved in ultra pure water as the internal water phase. Oil
phase comprised of 50 mg PLGA (50:50 with inherent viscosity range from 0.55 to 0.75 dL.g-1
in Hexafluoroisopropanol) in 1000 μL acetone. Then 500 μL BSA or TGF-β1/BSA aqueous
solution was added into the PLGA solution and emulsified for 55 s using a sonicator at an out-
put power of 500W at 20 kHz. This first emulsion (w/o) was decanted into 10 mL ultra pure
water to produce a double w/o/w emulsion. The microsphere containing solution was stirred
for 30 min at room temperature to remove the organic solvent. For the introduction of micro-
spheres, an electrospun fibrous mat was punched into 8 mm diameter test samples and placed
in a 48-well plate. 500 μL of the microsphere suspension was injected to the well plate followed
by shaking for 2 h.
CAP Device
The CAP device employed in this study utilized the dielectric barrier discharge of helium gas
which has been characterized in detail in our previous work.[18, 22] The electrodes for plasma
production were composed of a 1 mm diameter central electrode wrapped with a grounded
outer electrode of 4.5 mm diameter quartz tube. A high output voltage of 3.6 kV with a fre-
quency of 13 kHz was applied to generate homogenous plasma through delivery of the helium
gas. The flow rate of helium was kept constant at 5 L.min-1.
Scaffolds were treated by directly placing the scaffolds beneath the plasma electrode at a dis-
tance of 2 cm. Samples were exposed to CAP for 1 min, 3 min, and 5 min, respectively and
characterized and evaluated for MSC culture studies.
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Characterization of Microspheres and Scaffolds
Microsphere morphology was examined by scanning electron microscopy (SEM, Zeiss NVi-
sion 40 FIB) at an accelerating voltage of 2 kV after sputter coating with gold. The size distribu-
tion of microspheres was determined from SEMmicrographs using image analysis software
(Image J, National Institutes of Health, USA). BSA encapsulation efficacy was tested by dissolv-
ing microspheres in 0.1 M NaOH aqueous and quantified using a protein assay reagent kit
(Pierce Biotechnology).
The surface morphology of scaffolds was examined using SEM at 3 kV accelerating voltage
with gold coating as well. A video contact angle system (DSA4, Krüss) was employed to deter-
mine the wettability (or hydrophilicity) of the electrospun scaffolds with and without CAP
treatment. An ultra-pure water droplet of 0.9 μL was automatically deposited on the samples’
surface using a syringe. Three samples were measured for each test. Protein adsorption includ-
ing fibronectin and vitronectin upon treated and untreated scaffolds was conducted by an
enzyme-linked immunosorbent assay (ELISA). Briefly, scaffolds were incubated in Dulbecco’s
modified Eagle’s medium (DMEM, Lonza) with and without fetal bovine serum (10%) (Atlanta
Biologicals) for 24 h at 37°C. After washing with phosphate buffer saline (PBS) and blocking
with 2% BSA for 1 h, the first antibody solution (fibronectin antibody, 1:100 or vitronectin
antibody, 1:100, Thermo Scientific) was added to each scaffold. Goat anti-mouse lgG (H + L)
(1:100 in 1% BSA, Life Technologies) serving as the secondary antibody was added prior to
Fig 1. Schematic illustration of microspheres embedded electrospun cartilage scaffolds preparation and CAPmodification.
doi:10.1371/journal.pone.0134729.g001
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incubating for 1 h using Tween 20 (0.05% in PBS). Then, samples were incubated with 2,2’-
azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (Vector Labs) solution for 20 min at room
temperature in the dark followed by reading the absorbance at 405 nm by a spectrophotometer
(Thermo Scientific Multiskan GO).
Compression testing of all samples (circular samples of 5 mm in diameter) was analyzed
using an ATS uniaxial mechanical tester equipped with a 100 N load cell at a cross-head speed
of 0.2 mm.s-1 under ambient condition.
MSC Culture and in vitro Proliferation Study
Primary MSCs were harvested from healthy consenting donor’s iliac crest (Female; Age: 27) at
Tulane University under an IRB-approved protocol with informed consent. And then they are
distributed from the Texas A&MHealth Science Center, Institute for Regenerative Medicine
and are thoroughly characterized. We had the fully executed Material Transfer Agreement that
was needed to obtain the cells, which provides verification that we in fact did not obtain the
cells from the donors themselves. Passage number 3 to 6 was used for all of the following cell
studies. MSCs were cultured in Alpha Minimum Essential medium (α-MEM, Gibco) supple-
mented with 16.5% fetal bovine serum, 1% (v/v) L-glutamine (Invitrogen), and 1% penicillin/
streptomycin (Invitrogen) in a 75 cm2 cell culture flask. Cells were incubated at 37°C in a
humidified atmosphere containing 5% CO2 and media was changed every other day.
For cell proliferation studies, circular specimens (8 mm in diameter) were sterilized under
UV for 20 min, rinsed three times with PBS and subsequently prewet in media overnight prior
to cell seeding. To test the efficiency of loaded bioactive factor (BSA), three sample groups
(bare PCL, PCL with directly sprayed BSA, and PCL with BSA encapsulated microspheres)
were prepared. In addition, samples with embedded microspheres were treated under varying
CAP exposure times (0 min as control, 1 min, 3 min) and studied to evaluate the influence of
CAP treatment on cell behavior. Cells were seeded at a density of 10,000 per scaffold. At prede-
termined time points, the cell number was quantified by a non-radioactive cell proliferation
assay (MTS assay, Promega). The absorbance of each well was analyzed at 490 nm using a
Thermo Scientific Multiskan GO spectrophotometer.
Immunofluorescence Microscopy
Immunofluorescence was used to analyze MSC spreading and infiltration in the scaffolds after
1, 3, and 5 days culture. Samples were fixed with 10% formaldehyde for 10 min before rinsing
3× with PBS and permeabilizing with 0.05% Triton X-100 and double staining with Rhoda-
mine-Phalloidin (Life Technologies) and 4’-6-diamidino-2-phenylindole (DAPI, Sigma-
Aldrich) for F-actin and cell nucleus. Fluorescent images were visualized using a laser scanning
confocal microscope (LSCM 710, Zeiss). Z-stack images were obtained to qualitatively evaluate
cell migration throughout the scaffolds with infiltration depth quantitatively measured by
ImageJ.
MSC Chondrogenic Differentiation Study In Vitro
MSCs were seeded at a density of 100,000 cells/cm2 on each scaffold for chondrogenic differen-
tiation studies. Seeded scaffolds were maintained in chondrogenic media composed of com-
plete MSC media supplemented with 100 nM dexamethasone, 1% ITS+, 100 μg.mL-1 sodium
pyruvate, 40 μg.mL-1 proline and 50 μg.mL-1 L-ascorbic acid 2-phosphate. After 1, 2, and 3
weeks of culture, samples were washed in PBS, freeze-dried, and enzymatically digested in
Papain at 60°C for 18 h. Cartilage development was quantified on the basis of glycosaminogly-
can (GAG) content, type II collagen, and total collagen synthesis.
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GAG levels in digested solution were determined by binding of the acidic polymer to 1,
9-dimethylmethylene blue (DMB, Sigma-Aldrich). DMB solution was prepared by dissolving
16 mg DMB in 1 L water containing 3.04 g glycine, 1.6 g NaCl and 95 mL of 0.1 M acetic acid.
20 μL of digested samples was placed in a 96-well plate followed by the addition of 200 μL
DMB solution. Samples were then shaken for 5 seconds and the absorbance was immediately
measured at 524 nm.
Human type II collagen was evaluated via a type II collagen ELISA (TSZ ELISA) per the
manufacturer’s instructions. Briefly, aliquots of digested sample were added to a pre-coated
96-well plate containing purified human type II collagen antibody. After 40 min of incubation
at 37°C, samples were removed and rinsed with washing buffer. Biotinylated antibody was then
added to each well and incubated for an additional 20 min. Enzyme was added followed by
rinsing of the well plate with washing butter. Afterwards, a stop solution was sequentially
added and the absorbance was read at 450 nm.
Total collagen synthesis was evaluated using a sirius red colorimetric assay. Specifically,
sample aliquots were placed in a 96-well plate and dried overnight. Afterwards the samples
were washed with distilled water then 150 μL of 0.1% Sirius red stain (Direct Red 80, Sigma) in
saturated picric acid was added to each well and incubated for 1 hour at room temperature.
Wells were washed four times with acidified water (5% acetic acid) and incubated with 150 μL
0.1 M NaOH for 30 minutes at room temperature. The solutions of each well were transferred
to a new 96-well plate and read on a spectrophotometer at 550 nm.
Statistical analysis
All quantitative experiments were run in triplicate and data are presented as mean ± standard
error of the mean, unless indicated otherwise. Statistical analysis was carried out using stu-
dent’s t-test. A value of p<0.1 was considered statistically significant.
Results
Preparation and Characterization of CAP Treated Scaffolds with
Microspheres
The SEM images of test samples were shown in Fig 2. Following optimized electrospinning con-
ditions as described in our previous studies [24], electrospun fibers were successfully fabricated
without beading. The fibers exhibited random orientation with uniform fiber size and intercon-
nected pores. Homogenous microsphere distribution upon the scaffolds can be observed (Fig 2B
and 2b). In addition, CAP treatment did not alter the scaffold surface morphology after 1 min
(Fig 2C and 2c) and 3 min (Fig 2D and 2d) of exposure, respectively. However, 5 min CAP
exposure led to scaffold degradation resulting in the fiber aggregation (Fig 2E and 2e), which
indicates prolonged CAP exposure can alter scaffold surface and gross morphology.
In an effort to characterize the microsphere delivery system employed here, BSA-loaded
PLGA microspheres were fabricated via a w/o/w double emulsion solvent extraction method,
microscopically examined, and evaluated for bioactive factor encapsulation. Fig 3 shows the
spheres have a uniform spherical morphology with a mean diameter size of 0.432 μm. In addi-
tion, the BSA-loaded microspheres exhibit a high encapsulation efficacy of 73.2% and 12.3%
loading efficiency.
In addition to morphology, the surface properties of scaffolds including hydrophilicity and
protein adsorption significantly influence scaffold performance and cytocompatibility [25].
Therefore, the hydrophilicity (contact angle) of scaffolds exposed under various CAP treatment
times was measured (Fig 4). Scaffolds without CAP treatment exhibited a contact angle value
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Fig 2. SEM analysis of various scaffolds. Low- and high-magnification of SEM images of (A, a) unmodified
control scaffold without microspheres, (B, b) unmodified scaffold with microspheres, (C, c) CAP-modified
scaffolds with 1 min, (D, d) 3 min and (E, e) 5 min treatment time.
doi:10.1371/journal.pone.0134729.g002
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Fig 3. SEM images of microspheres (A-B) and their size distribution (C).
doi:10.1371/journal.pone.0134729.g003
Fig 4. Contact angle comparison of scaffolds with and without CAP treatment.Data are mean ± standard error of the mean, n = 3; *p<0.05.
doi:10.1371/journal.pone.0134729.g004
CAPModified Cartilage Scaffold with Microspheres
PLOS ONE | DOI:10.1371/journal.pone.0134729 July 29, 2015 8 / 18
of 117.3° indicating a hydrophobic surface. After CAP treatment, we found the contact angle
significantly decreased and exhibited a linear dependence to exposure time. After 1 min CAP
treatment, a slight decrease (92.7°) of contact angle was observed. After 3 min CAP exposure,
the contact angle sharply decreased by 61.3% (34.8° contact angle) when compared to an
untreated control, suggesting the induction of a hydrophilic surface. Extended exposure (up to
5 min) further increased surface hydrophilicity where the contact angle decreased to 14.2°.
Based on the contact angle results, we further investigated specific vitronectin and fibronec-
tin adsorption on microsphere-embedded scaffolds after CAP exposure. Specifically, CAP
exposure increased vitronectin adsorption by 10.6% and 13% after 1 and 3 min treatment
times, respectively, when compared to an untreated control (Fig 5A). There was no significant
difference in fibronectin adsorption amongst the sample groups (Fig 5B).
Fig 6 shows the compressive modulus of CAP modified and unmodified scaffolds with
embedded microspheres. The unmodified scaffold exhibited a compressive modulus of 248
KPa with CAP modification slightly decreasing the compressive modulus. Specifically, after 1
min of CAP exposure the scaffold exhibited a compressive modulus of 201 KPa. With increas-
ing CAP treatment, the compressive modulus decreased to 137 and 136 KPa corresponding to
3 min and 5 min exposure time, respectively.
Enhanced MSC Proliferation on Scaffolds with CAP Treatment and
Microspheres
In an effort to evaluate the effects of CAP treatment on MSC behavior, 1, 3, and 5 day cell prolif-
eration was performed on scaffolds with embedded microspheres exposed to CAP treatment.
Results show that all experimental groups exhibited excellent biocompatibility as well as
increased cell proliferation over time (Fig 7). More importantly, CAP treatment further enhanced
MSC proliferation, displaying a time dependent growth profile. Specifically, scaffolds exposed to
CAP for 3 minutes displayed the highest cell proliferation with an increased cell number of
17.3% when compared to an untreated control (0 min) after 5 days of culture. Scaffolds exposed
to 1 min CAP treatment time exhibited a 10.9% increase in cell number after 5 days.
In addition, the contribution of bioactive factor loaded microspheres on 3, 5, and 7 day MSC
proliferation was also evaluated (Fig 8). Samples included electrospun fibers with BSA-loaded
microspheres, directly sprayed BSA (identical amount bare BSA was directly sprayed on the sur-
face of scaffolds without microsphere encapsulation), and bare scaffolds only (control). Here,
Fig 5. Proteins adsorption on scaffolds with different CAP treatment times. Specific (A) vitronectin and (B) fibronectin adsorption on scaffolds after 0, 1
and 3 min CAP treatment by ELISA assay, data are mean ± standard error of the mean, n = 3. *p<0.05.
doi:10.1371/journal.pone.0134729.g005
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BSA was selected as a model bioactive factor to illustrate the function of microspheres on regu-
lating cell behavior. Results reveal that MSC number was similar amongst all groups with no sig-
nificant difference after 3 and 5 days culture. When the culture time was extended to 7 days,
both BSA-loaded microspheres and directly sprayed BSA groups had significantly increased cell
Fig 6. Compressive modulus of CAPmodified and unmodified (0 min) scaffolds. Sample thickness is 0.5 mm, data are mean ± standard error of the
mean, n = 3, *p<0.05.
doi:10.1371/journal.pone.0134729.g006
Fig 7. Enhanced MSC proliferation on CAPmodified scaffolds after 3 and 5 days.Data are mean ± standard error of the mean, N = 3, *p<0.05.
doi:10.1371/journal.pone.0134729.g007
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proliferation when compared to bare scaffolds. The greatest MSC proliferation was observed on
BSA-loaded microsphere scaffolds with a 14.4% and 34.5% increase when compared to BSA-
sprayed and control scaffolds after 7 days of culture, respectively.
Moreover, confocal microscopy was carried out on various MSC seeded scaffolds including
bare scaffolds, scaffolds with CAP treatment, and scaffolds with both CAP treatment and BSA-
loaded microspheres to evaluate 3D cell spreading and infiltration. As shown in Fig 9, excellent
MSC adhesion and spreading was observed throughout the entirety of the CAP and micro-
sphere embedded scaffolds’ surface with well-defined actin filaments (stained red by Rhoda-
mine-Phalloidin) and nuclei (stained blue by DAPI) suggesting desirable biocompatibility of
the scaffold groups. More importantly, CAP treated scaffolds (with and without microspheres)
can substantially enhance 3D cell infiltration when compared with PCL scaffolds without CAP
treatment after 1 and 3 days culture, respectively. Image analysis revealed a 2.22 and 2.07-fold
increase of infiltration depth for 1 min and 3 min CAP treated scaffolds, respectively, when
compared to untreated scaffolds at day 1. At day 3, the infiltration depth on scaffolds with 1
min and 3 min CAP treatment was 1.68 and 1.58 times relative to untreated scaffolds. There
was no significant difference in cell infiltration depth amongst CAP treated groups with and
without microspheres at day 1 and day 3.
CAP and Microspheres Synergistically Improved Chondrogenic
Differentiation of MSCs
GAG is a critical component of native cartilage extracellular matrix which plays a significant
role in recruiting growth factors, cytokines, and water retention [26]. Enhancing GAG secre-
tion is extremely desirable for scaffolds targeting cartilage tissue repair. Thus, we quantified
deposited GAG content upon our scaffolds after culturing MSCs in chondrogenic media for 1,
2, and 3 weeks. Samples included bare PCL control, microsphere-embedded scaffolds, and
CAP treated scaffolds with and without embedded microspheres. Specifically, TGF-β1 as an
inducer of chondrogenesis was encapsulated within the microspheres. Results showed an
Fig 8. MSC proliferation after 3, 5 and 7 days culture. Samples include bare PCL scaffolds (as control), PCL scaffolds with directly sprayed BSA, and
scaffolds with BSA-loaded microspheres, data are mean ± standard error of the mean, N = 3, *p<0.05.
doi:10.1371/journal.pone.0134729.g008
CAPModified Cartilage Scaffold with Microspheres
PLOS ONE | DOI:10.1371/journal.pone.0134729 July 29, 2015 11 / 18
Fig 9. Confocal micrographs of MSCs spread and proliferate on various scaffolds. At day 1 (A) and day
3 (B) cells penetrated to scaffolds with different cells infiltration distance for 1 day (a) and 3 days (b).
Improved cell proliferation and infiltration were observed on scaffolds with CAP treatment and/or
microspheres incorporation compared to PCL only control group. Data are mean ± standard error of the
mean, N = 3, *p<0.05.
doi:10.1371/journal.pone.0134729.g009
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increase in GAG production over time for all scaffolds in the first two weeks (Fig 10), and CAP
treated groups with microspheres exhibited more GAG content than bare PCL control in week
2. After 3 weeks, scaffolds with both CAP treatment and microspheres showed the highest
increase in GAG synthesis when compared to all other groups.
In addition to total GAG content, type II collagen (another important indicator of MSC
chondrogenesis) was evaluated. As shown in Fig 11A, type II collagen synthesis was signifi-
cantly improved after each time point for the scaffolds with CAP treatment, embedded micro-
spheres, and both CAP and embedded microsphere modification when compared to control.
Additionally, total collagen quantification (Fig 11B) demonstrated that scaffolds with CAP
treatment and embedded microspheres outperformed the bare control after three weeks of cul-
ture. These results help to illustrate the synergistic promotion of CAP and bioactive micro-
spheres for regulated MSC chondrogenic differentiation in vitro.
Discussion
Integrating CAP and Electrospinning for Fabricating Bioactive Cartilage
Scaffold
Electrospinning has been widely investigated in tissue engineering fields and showed promise
in promoting various desired cellular activities [27–30]. However, the lack of ideal bioactive
surface properties and excellent 3D cell infiltration nature within many electrospun scaffolds is
a major concern typically resulting in less than ideal tissue regeneration. Even though many
traditional approaches are available to modify the electrospun scaffolds as described in the
introduction section, a simple, efficient, and one-step modification method is still highly desir-
able. Therefore, in this report, we uniquely combined CAP with electrospinning in an effort to
yield a more bioactive and biomimetic scaffold for cartilage regeneration.
Fig 10. GAG secretion in various scaffolds. Enhanced GAG secretion in CAPmodified microspheres incorporated scaffolds relative to controls after three
weeks culture, data are mean ± standard error of the mean, N = 3, *p < 0.05, &p<0.1.
doi:10.1371/journal.pone.0134729.g010
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CAP is an emerging medical technique which holds great promise for biomedical applica-
tions, its complex composition renders it capable of remodeling and altering the scaffold
microarchitecture and surface properties [22]. Our results demonstrate that CAP treatment
can easily render the inherent hydrophobic surface properties of electrospun PCL scaffolds
(contact angle = 134°) to more hydrophilic (contact angle = 34.8° after 3 min CAP treatment)
Fig 11. Type II collagen and total collagen synthesis. Scaffolds with CAP treated, microspheres embedded, and both CAP and microspheres modification
promoted (A) type II collagen and (B) total collagen synthesis relative to bare control, data are mean ± standard error of the mean, N = 3, *p < 0.05, &p<0.1.
doi:10.1371/journal.pone.0134729.g011
CAPModified Cartilage Scaffold with Microspheres
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in a one-step process as well as enhance specific protein adsorption for better cell adhesion
(Figs 4 and 5). It is worth noting that CAP treatment could be precisely controlled to avoid
scaffold surface damage (Fig 2). Although a slight decrease in compressive modulus after CAP
treatment was observed, it still remains in the modulus range of native cartilage (0.1–2 MPa)
[31]. It is postulated that the observed alteration of bulk mechanical properties is ascribed to a
change in compressive strength of individual fibers. In addition, the softer surface induced by
CAP treatment probably contributed partially to improved cell functions, such as proliferation
and chondrogenic differentiation.
The influence of CAP on scaffold surface properties may be attributed to the introduction
of oxygen-containing charged species deposited upon the scaffold surface [32]. It is well known
that the CAP plume contains various reactive oxygen species. The oxygen-rich plasma treat-
ment can introduce oxygen-containing species, such as C-O, C = O, O-C = O, C-O-O, and
CO3, upon the polymer surface leading to reactions between the polymer chain and atomic
oxygen found within the CAP plume [33]. Not only does the addition of reactive oxygen spe-
cies improve material hydrophilicity, better protein adsorption leading to enhanced cell attach-
ment and proliferation [34, 35].
Our cell proliferation results (Fig 7) confirm the promotion of cell proliferation with an
increase of CAP treatment time. Other studies suggest improved cell response as a result of alter-
ations to the surface roughness caused by CAP surface modification [22, 36]. Increases in surface
roughness promote cell attachment, morphological changes, and differentiation [37]. In addition
to the promotion of cell proliferation, qualitative evaluation by confocal microscopy displays
excellent cell spreading and growth on CAP modified scaffolds when compared to untreated
samples (Fig 9). More importantly, MSCs exhibited much deeper cellular infiltration on CAP
treated scaffolds than untreated controls after 1 and 3 days of culture. Traditional electrospun
scaffolds are always limited by their poor cell infiltration due to tightly compacted fibrous layers.
In order to address this, many approaches have been investigated such as the incorporation of
nanoparticles, enlarge microfibers, leaching embedded salt [38]. However, these conventional
strategies routinely involve laborious procedures, and may influence the integrity of original
scaffolds as well as impair the scaffolds’ bioactive properties. Our results indicate CAP treatment
is a robust tool for the modification of electrospun scaffolds with greatly improved cell infiltra-
tion capacity. This easy one-step modification strategy may be opening a new avenue to tackle
the challenge of electrospun scaffolds for various tissue engineering applications.
Incorporating Microspheres into CAP Treated Scaffolds to Provide
Sustained Bioactive Factor Environment
MSC and chondrocytes are excellent cell sources for repairing articular cartilage defects [39,
40]. When compared to chondrocytes, the use of MSCs exhibits superiority in cartilage regen-
eration. MSCs are readily acquired from the bone marrow or other mesenchyme-derived tis-
sues while mature chondrocytes can only be harvested from a limited supply of healthy
articular cartilage. The harvesting of MSCs does not require the use of cartilage biopsy which
further lowers complications associated with donor-site morbidity [41, 42]. During the use of
MSCs, some key factors are considered as potential strategies to enhance MSC-based cartilage
repair. TGF-β1, a member of the TGF-β superfamily, can stimulate chondrogenesis of MSC
resulting in the enhanced production of cartilaginous extracellular matrix [43]. Therefore, the
development of scaffolds with controlled delivery of bioactive TGF-β1 can provide temporal
and spatial control of MSC differentiation both in vitro and in vivo.
Consequently, in addition to CAP surface modification, we introduced a microsphere-based
sustained bioactive factor delivery system to be used in combination with electrospun fibrous
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scaffolds. In order to evaluate the efficacy of bioactive microspheres, we first loaded BSA within
the microspheres, and performed a 7 day cell proliferation study. Results show increased cell
number at day 7 in groups containing sprayed BSA and BSA loaded microspheres when com-
pared to control (Fig 8). In particular, the group containing BSA loaded microspheres exhibit
the highest cell growth after 7 days of culture. This may be due to the rapid diffusion of bare
BSA when directly spayed upon PCL fibrous scaffolds where most of the BSA would be
removed during regular media exchange resulting in the absence of long-term stimulation. In
contrast, microspheres incorporated with the scaffold matrix can protect BSA and allow for
release of BSA for a longer term when compared to bare BSA in the scaffold.
Similarly, improved cellular response was observed when TGF-β1 was loaded within the
microspheres during the 3-week differentiation study (Figs 10 and 11). A significant increase
in total GAG and type II collagen was noted in the CAP treated and microsphere embedded
scaffold group which can be attributed to both sustained release of TGF-β1 and CAP treatment
for improved cellular function.
As a whole, our findings suggest a synergistic effect between CAP and bioactive factor encap-
sulated microspheres where both CAP treatment and sustained bioactive factor delivery micro-
spheres allow for greater cell growth and elevated cellular activities. For the first time, we find
CAP has the capacity in improving cell infiltrating into electrospun scaffolds and chondrogenic
differentiation. Thus, the integrated techniques used in this study hold high potential in cartilage
regeneration, and, not limited to cartilage application, it could be considered to create next gen-
eration of bioactive tissue-engineered scaffolds for various tissue regeneration applications.
Conclusion
A series of novel CAP modified cartilage scaffolds were fabricated in the current study and
they displayed interconnected porous topography with homogeneously distributed micro-
spheres. Surface modification via CAP treatment in combination with bioactive factors encap-
sulated microspheres promoted MSC growth, 3D infiltration, and chondrogenesis. CAP
treatment alone can readily enhance adhesion-mediating protein adsorption (vitronectin) on
PCL scaffolds and, thus, promote MSC function. Quantitative biochemical assays confirm the
enhanced synthesis of GAG, type II collagen and total collagen on microsphere embedded
CAP treated scaffolds after three weeks of culture. Collectively, our work suggests this novel
CAP treated scaffold can be used as a potential construct for cartilage regeneration. Further-
more, the combination of CAP technique, bioactive factor loaded microspheres and electro-
spinning holds great promise for a variety of tissue regeneration.
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